OXYCODONE HYDROCHLORIDE: payments to doctors
Payments that named OXYCODONE HYDROCHLORIDE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.2M
- Providers
- 2
- Transactions
- 55
- Average per transaction
- $22,724
The per-transaction average — $22,724 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2 providers the average total is $624,908, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Hikma Pharmaceuticals USA | $1,248,969 | 99.9% |
| Par Pharmaceutical, Inc. | $394 | 0.0% |
| Endo USA, Inc. | $350 | 0.0% |
| Endo Pharmaceuticals Inc. | $103 | 0.0% |